Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial is evaluating first-line treatment with carboplatin plus mirvetuximab soravtansine for advanced-stage ovarian, fallopian tub…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers [Phase 2]
Phase 2 clinical trial update evaluating cryocompression with or without cilostazol to prevent paclitaxel-induced neuropathy in gynecologic …
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Abemaciclib for recurrent gynecologic cancers, including endometrial, fallopian tube, ovarian, and pr…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovar…
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer [Phase 2]
Phase 2 study evaluating personalized timing of interval debulking surgery for advanced ovarian cancer. The trial is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-30Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; th…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Surgery for Relapsed Ovarian Cancer in Precision [Phase 1, Phase 2]
A precision medicine-guided surgical approach for relapsed ovarian, fallopian tube, and primary peritoneal cancers is being explored in Phas…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial is evaluating ZEN003694 in combination with Talazoparib for recurrent ovarian cancer and related gynecologic cancer…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating ONC-201 in combination with weekly paclitaxel for platinum-refractory or resistant ovarian cancer; current…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor combined with a CTLA-4 blocker in BRCA-deficient ovarian cancer, including fallopian tu…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer [Phase 2]
An ongoing Phase 2 study evaluating pembrolizumab in combination with chemotherapy for platinum-sensitive recurrent low-grade serous ovarian…
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors [Phase 1]
A Phase 1 trial is evaluating the addition of Elimusertib, an ATR inhibitor, to gemcitabine for advanced pancreatic and ovarian cancers and …
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) [NA]
A clinical trial named PRESERVE is evaluating perioperative stress reduction versus standard of care in patients with ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
This clinical trial update compares SYMMCORA and V-Loc barbed sutures in patients undergoing laparoscopic total hysterectomy, with recruitme…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
This clinical trial update describes a Stanford-sponsored study investigating BRCA1/BRCA2-associated tumors and the collection of related tu…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer [Phase 3]
This update notes a Phase 3 trial evaluating relacorilant in combination with nab-paclitaxel for advanced platinum-resistant ovarian, primar…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial update for Mirvetuximab soravtansine (IMGN853) in FRα-high recurrent ovarian, fallopian tube, or primary peritoneal…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors [NA]
Phase I clinical trial evaluating CAR-T cell therapy for advanced gynecologic solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University is conducting a specimen and data study for ovarian cancer early detection and prevention. The trial is currently re…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers [NA]
This entry reports on the development of a clinical and biological database for ovarian, fallopian tube, and peritoneal cancers, sponsored b…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) [Phase 3]
Phase 3 clinical trial SUNNY compares upfront surgery to neoadjuvant chemotherapy in advanced ovarian cancer. The study is currently active …
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update for JSKN003 in platinum-resistant, relapsed epithelial ovarian cancer; the study is currently not yet recruiting.